SCCA1 expression in T-lymphocytes peripheral to cancer cells is associated with the elevation of serum SCC antigen in squamous cell carcinoma of the tongue

Yasumatsu, Ryuji; Nakashima, Torahiko; Azuma, Kaoru; Hirakawa, Naoya; Kuratomi, Yuichiro; Tomita, Kichinobu; Çataltepe, Sule; Silverman, Gary A.; Komiyama, S.

doi:10.1016/s0304-3835(01)00445-1

Cited by 25 publications

(29 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[25], [26] The pro-invasive characteristics of SCC-Ag have also demonstrated positive associations between serum SCC-Ag level and tumor progression, lymph node metastasis and tumor stage. [4], [27], [28], [29], [30], [31], [32] The present study also confirmed the positive relationship between SCC-Ag level and clinical stage, clinical tumor status, and clinical nodal status (P = 0.001, P<0.001, P = 0.001, respectively) (Table 2). In response to stimulation by epidermal growth factor, intracellular SCC-Ag has been shown to translocate to the plasma membrane, and exogenously expressed SCC-Ag then serves to increase cell migration without affecting cell growth.…”

Section: Discussionsupporting

confidence: 85%

Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma

et al. 2013

View full text Add to dashboard Cite

The levels of squamous cell carcinoma antigen (SCC-Ag) and C-reactive protein (CRP) can be used to predict tumor invasion, lymph node metastasis, staging and survival in patients with oral cavity cancer. The present study analyzed the relationship between pre-treatment levels of SCC-Ag and CRP in relation to clinicopathological factors in patients with pharyngolaryngeal cancer (PLC) and determined whether elevated levels of CRP and SCC-Ag were associated with tumor metabolic activity via [18F] fluorodeoxyglucose positron emission tomography (FDG-PET). We retrospectively recruited one hundred and six PLC patients between June 2008 and December 2011. All patients received computed tomography (CT)/magnetic resonance imaging (MRI) and FDG-PET staging analyses, and the serum levels of SCC-Ag and CRP in these patients were measured prior to treatment. A SCC-Ag level ≥2.0 ng/ml and a CRP level ≥5.0 mg/L were significantly associated with clinical stage (P<0.001), clinical tumor status (P<0.001), and clinical nodal status (P<0.001). The elevation of both SCC-Ag and CRP levels was correlated with the standardized uptake value (SUV) max of the tumor (≥8.6 mg/L) and lymph nodes (≥5.7 ng/ml) (P = 0.019). The present study demonstrated that the presence of high levels of both pre-treatment SCC-Ag and CRP acts as a predictor of clinical stage, clinical tumor status, and clinical nodal status in patients with PLC. Moreover, elevated levels of SCC-Ag and CRP were associated with a high metabolic rate as well as the proliferative activity measured according to the SUVmax of the tumor and lymph nodes. Therefore, elevated levels of these two factors have the potential to serve as biomarkers for the prediction of tumor aggressiveness in cases of PLC.

show abstract

Section: Discussionsupporting

confidence: 85%

Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma

et al. 2013

View full text Add to dashboard Cite

show abstract

“…Furthermore, the pro-invasive ability of SCC-Ag has been supported by clinical studies demonstrating positive relationships between serum SCC-Ag levels and tumor progression, lymph node metastasis, and tumor stage. [4], [13], [19], [24], [25], [26] In our study, we demonstrated that the SCC-Ag was significantly lower after treatment in OSCC (Fig. S1A).…”

Section: Discussionsupporting

confidence: 54%

Using SCC Antigen and CRP Levels as Prognostic Biomarkers in Recurrent Oral Cavity Squamous Cell Carcinoma

et al. 2014

View full text Add to dashboard Cite

Squamous cell carcinoma antigen (SCC-Ag) and C-reactive protein (CRP) levels have been successfully used to stratify risk groups in primary oral squamous cell carcinoma (OSCC) patients; however, related biomarkers have rarely been investigated in recurrent OSCC. The purpose of the present study was to analyze the relationships of SCC-Ag and CRP levels at the time of recurrence with clinical factors and prognosis. We retrospectively recruited patients with recurrence in a cohort of 534 OSCC patients between March 2001 and July 2013. One hundred patients had recurrence. The serum SCC-Ag and CRP levels were measured at the time of cancer diagnosis, 3 to 6 months after treatment with clinical disease-free, and at the time of recurrence. The SCC-Ag levels were significantly lowered after treatment (paired t-test: p = 0.001) and re-elevated at the time of recurrence (paired t-test: p = 0.027). An SCC-Ag level ≥2.0 ng/ml and a CRP level ≥5.0 mg/L at the time of recurrence were significantly associated with recurrent tumor status (P<0.001), recurrent nodal metastasis (χ2 trend test: P = 0.020), distant metastasis (P<0.001), and overall survival (P<0.001). Moreover, the influence of both elevated SCC-Ag and CRP levels on overall survival (P<0.001, H.R. [95% CI]: 5.406 [2.210–13.222]) still existed after adjusting for the recurrent tumor stage and patient age. The present study demonstrates that concurrent high levels of both SCC-Ag and CRP at the diagnosis of recurrence acts as a predictor of recurrent tumor status, recurrent advanced tumor stage, distant metastasis, and survival after the diagnosis of recurrence. This study expands the applicability of these two markers in the risk stratification in recurrent OSCC.

show abstract

“…Yasumatsu et al 18 reported a significant relationship between SCCA levels and the Krouse classification. However, the SCCA level in our previous study 10 was not significantly correlated with clinical characteristics, including the Krouse classification.…”

Section: Discussionmentioning

confidence: 99%

Squamous Cell Carcinoma Antigen as a Diagnostic Marker of Nasal Inverted Papilloma

Yamashita

Uehara

Hasegawa

et al. 2016

Am J Rhinol�Allergy

View full text Add to dashboard Cite

show abstract

SCCA1 expression in T-lymphocytes peripheral to cancer cells is associated with the elevation of serum SCC antigen in squamous cell carcinoma of the tongue

Cited by 25 publications

References 25 publications

Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma

Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma

Using SCC Antigen and CRP Levels as Prognostic Biomarkers in Recurrent Oral Cavity Squamous Cell Carcinoma

Squamous Cell Carcinoma Antigen as a Diagnostic Marker of Nasal Inverted Papilloma

Contact Info

Product

Resources

About